1:39 PM
 | 
Jun 11, 2019
 |  BC Innovations  |  Distillery Therapeutics

Inhibiting BCL10 or MALT1 for melanoma

DISEASE CATEGORY: Cancer

INDICATION: Melanoma

Mouse studies suggest inhibiting BCL10 or MALT1 could help treat melanoma. In a syngeneic mouse model of melanoma, Treg-specific knockout of BCL10 decreased...

Read the full 112 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >